Search

Your search keyword '"Álvaro del Amo Fernández de Velasco"' showing total 2 results
Start Over Author "Álvaro del Amo Fernández de Velasco"
2 results on '"Álvaro del Amo Fernández de Velasco"'

1. Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw

Author

Sandra Bacián Martínez, Carlos Navarro Cuéllar, Carlos Navarro Vila, Edurne Palacios Weiss, Roser Pujol Romanyá, Álvaro del Amo Fernández de Velasco, Margarita Escrig de Teijeiro, José Luis del Castillo Pardo de Vera, Irene Rodríguez Pérez, Arturo Sánchez-Pérez, José J. Zamorano-León, Antonio López-Farré, María Isabel García-Hidalgo Alonso, and Ignacio Navarro Cuéllar

Subjects
denosumab, medication related osteonecrosis of the jaw (MRNOJ), primary intraosseous squamous cell carcinoma, Technology, Engineering (General). Civil engineering (General), TA1-2040, Biology (General), QH301-705.5, Physics, QC1-999, Chemistry, QD1-999
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose mechanism of action is to prevent the activation of the RANK receptor on the surface of osteoclasts, has been associated with osteonecrosis of the jaw. Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare neoplasm characterised by the presence of squamous cells within the maxillary or mandibular bone without an initial clinical association with the oral mucosa. We present a case of a PIOSCC in an osteonecrosis of the jaw related to a patient who received antiresorptive treatment with denosumab outlining the clinical and histopathological features of MRONJ and PIOSCC.

Published
2021
Full Text
View/download PDF

2. Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw

Author

Arturo Sánchez-Pérez, Roser Pujol Romanyá, Margarita Escrig de Teijeiro, Sandra Bacián Martínez, M.I. Alonso, Álvaro del Amo Fernández de Velasco, Irene Rodríguez Pérez, Ignacio Navarro Cuéllar, Edurne Palacios Weiss, Carlos Navarro Cuéllar, José J. Zamorano-León, Antonio López-Farré, Carlos Navarro Vila, and José Luis del Castillo Pardo de Vera

Subjects
Technology, Pathology, medicine.medical_specialty, primary intraosseous squamous cell carcinoma, QH301-705.5, QC1-999, Farmacología, Odontología, stomatognathic system, medicine, medication related osteonecrosis of the jaw (MRNOJ), General Materials Science, Basal cell, Biology (General), QD1-999, Instrumentation, Fluid Flow and Transfer Processes, business.industry, Physics, Process Chemistry and Technology, General Engineering, denosumab, Engineering (General). Civil engineering (General), medicine.disease, Computer Science Applications, Chemistry, stomatognathic diseases, Denosumab, TA1-2040, business, Osteonecrosis of the jaw, medicine.drug
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose mechanism of action is to prevent the activation of the RANK receptor on the surface of osteoclasts, has been associated with osteonecrosis of the jaw. Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare neoplasm characterised by the presence of squamous cells within the maxillary or mandibular bone without an initial clinical association with the oral mucosa. We present a case of a PIOSCC in an osteonecrosis of the jaw related to a patient who received antiresorptive treatment with denosumab outlining the clinical and histopathological features of MRONJ and PIOSCC.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results